Revenue - Hbm Holdings Ltd (HKEX:2142) - Alpha Spread
H

Hbm Holdings Ltd
HKEX:2142

Watchlist Manager
Hbm Holdings Ltd
HKEX:2142
Watchlist
Price: 1.24 HKD 0.81% Market Closed
Market Cap: 952.9m HKD
Have any thoughts about
Hbm Holdings Ltd?
Write Note

Hbm Holdings Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hbm Holdings Ltd
Revenue Peer Comparison

Comparables:
C
8158
690
775
1061

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
H
Hbm Holdings Ltd
HKEX:2142
Revenue
$89.5m
CAGR 3-Years
85%
CAGR 5-Years
127%
CAGR 10-Years
N/A
C
China Regenerative Medicine International Ltd
HKEX:8158
Revenue
HK$69.5m
CAGR 3-Years
-27%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Uni-Bio Science Group Ltd
HKEX:690
Revenue
HK$508.4m
CAGR 3-Years
19%
CAGR 5-Years
24%
CAGR 10-Years
N/A
CK Life Sciences Intl (Holdings) Inc
HKEX:775
Revenue
HK$5.4B
CAGR 3-Years
1%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Essex Bio-Technology Ltd
HKEX:1061
Revenue
HK$1.6B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A

See Also

What is Hbm Holdings Ltd's Revenue?
Revenue
89.5m USD

Based on the financial report for Dec 31, 2023, Hbm Holdings Ltd's Revenue amounts to 89.5m USD.

What is Hbm Holdings Ltd's Revenue growth rate?
Revenue CAGR 5Y
127%

Over the last year, the Revenue growth was 120%. The average annual Revenue growth rates for Hbm Holdings Ltd have been 85% over the past three years , 127% over the past five years .

Back to Top